INCLUSIVE
7078
Renascience
4889
Chordia Therapeutics
190A
Kufu
4376
Cube
7112
(Q2)2024/08/31 | (Q1)2024/05/31 | (FY)2024/02/29 | (Q4)2024/02/29 | (Q3)2023/11/30 | (Q2)2023/08/31 | (Q1)2023/05/31 | (FY)2023/02/28 | (Q4)2023/02/28 | (Q3)2022/11/30 | |
---|---|---|---|---|---|---|---|---|---|---|
營業總收入 | 16.32%74.04億 | 13.37%57.63億 | 15.18%223.54億 | 12.19%49.92億 | 16.91%59.15億 | 16.19%63.65億 | 14.96%50.83億 | 18.09%194.08億 | 10.68%44.49億 | 21.07%50.6億 |
主營業務成本 | 16.51%57.46億 | 13.56%44.61億 | 14.74%173.37億 | 12.36%38.64億 | 17.21%46.13億 | 14.95%49.32億 | 14.03%39.28億 | 17.97%151.1億 | 9.86%34.39億 | 20.70%39.35億 |
毛利 | 15.69%16.58億 | 12.75%13.02億 | 16.73%50.18億 | 11.61%11.28億 | 15.84%13.03億 | 20.67%14.33億 | 18.25%11.54億 | 18.54%42.99億 | 13.55%10.1億 | 22.39%11.24億 |
營業費用 | 14.78%10.78億 | 7.13%9.6億 | 15.94%37.62億 | 11.10%9.73億 | 16.52%9.54億 | 16.27%9.39億 | 20.64%8.96億 | 19.23%32.45億 | 17.13%8.76億 | 23.22%8.18億 |
營業利潤 | 17.40%5.8億 | 32.28%3.42億 | 19.16%12.55億 | 14.95%1.54億 | 14.02%3.49億 | 30.05%4.94億 | 10.62%2.58億 | 16.46%10.53億 | -5.37%1.34億 | 20.21%3.06億 |
營業外利息收入與支出淨額 | 43.10%-43.7萬 | 31.83%-58.9萬 | 19.20%-267.7萬 | 29.78%-62萬 | -157.58%-42.5萬 | 28.62%-76.8萬 | 27.33%-86.4萬 | -25.30%-331.3萬 | 25.36%-88.3萬 | 72.50%-16.5萬 |
營業外利息收入 | 423.53%26.7萬 | 139.13%5.5萬 | -51.98%44.9萬 | 156.52%5.9萬 | -61.84%31.6萬 | 8.51%5.1萬 | -37.84%2.3萬 | 782.08%93.5萬 | -73.56%2.3萬 | --82.8萬 |
營業外利息支出 | -14.04%70.4萬 | -27.40%64.4萬 | -26.41%312.6萬 | -25.06%67.9萬 | -25.38%74.1萬 | -27.07%81.9萬 | -27.65%88.7萬 | 54.47%424.8萬 | -28.66%90.6萬 | 65.50%99.3萬 |
投資淨收益 | 86.59%503.8萬 | 0 | 0 | 0.00%270萬 | 0 | 0 | ||||
被指定為現金流套期的金融工具損益 | ||||||||||
終止確認可供出售金融資產損益 | 0 | 0 | 4,120.7萬 | 0 | 0 | 0 | 4,120.7萬 | 0 | 0 | 0 |
聯營企業及其他參股權益產生的收益 | ||||||||||
特殊收入(費用) | 0 | 2,417.8萬 | 96.93%-68.9萬 | 0 | -68.9萬 | 0 | 0 | -170.15%-2,240.9萬 | -74.7萬 | 0 |
減:其他特殊費用 | --0 | ---2,417.8萬 | -75.69%68.9萬 | --0 | ---- | ---- | ---- | 108.87%283.4萬 | --74.7萬 | --0 |
減:勾銷 | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --1,957.5萬 | --0 | --0 |
其他營業外收入(費用) | -24.34%31.4萬 | -51.02%26.4萬 | -23.18%141.5萬 | -86.62%12.3萬 | -28.54%33.8萬 | -35.46%41.5萬 | 379.27%53.9萬 | 10.04%184.2萬 | -26.83%91.9萬 | 168.45%47.3萬 |
稅前利潤 | 17.27%5.85億 | 22.18%3.65億 | 25.90%13億 | 15.18%1.54億 | 13.66%3.48億 | 30.27%4.99億 | 42.63%2.99億 | 10.72%10.32億 | -5.92%1.33億 | 16.68%3.06億 |
所得稅 | 19.10%2.13億 | 15.56%1.35億 | 27.14%4.38億 | 45.35%1,197.5萬 | 15.99%1.3億 | 29.84%1.79億 | 35.54%1.17億 | -4.70%3.44億 | -85.64%823.9萬 | 9.23%1.12億 |
除稅後利潤 | 16.25%3.71億 | 26.42%2.3億 | 25.28%8.62億 | 13.20%1.42億 | 12.32%2.19億 | 30.52%3.2億 | 47.58%1.82億 | 20.47%6.88億 | 48.26%1.25億 | 21.44%1.95億 |
持續經營利潤 | 16.25%3.71億 | 26.42%2.3億 | 25.28%8.62億 | 13.20%1.42億 | 12.32%2.19億 | 30.52%3.2億 | 47.58%1.82億 | 20.47%6.88億 | 48.26%1.25億 | 21.44%1.95億 |
歸屬于少數股東的淨利潤 | ||||||||||
歸屬於母公司的淨利潤 | 16.25%3.71億 | 26.42%2.3億 | 25.28%8.62億 | 13.20%1.42億 | 12.32%2.19億 | 30.52%3.2億 | 47.58%1.82億 | 20.47%6.88億 | 48.26%1.25億 | 21.44%1.95億 |
優先股派息 | ||||||||||
其他優先股派息 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
歸屬于普通股股東的淨利潤 | 16.25%3.71億 | 26.42%2.3億 | 25.28%8.62億 | 13.20%1.42億 | 12.32%2.19億 | 30.52%3.2億 | 47.58%1.82億 | 20.47%6.88億 | 48.26%1.25億 | 21.44%1.95億 |
總派息金額 | ||||||||||
基本每股收益 | 16.16%37.16 | 26.11%23.04 | 25.55%86.28 | 12.65%14.16 | 12.05%21.86 | 30.84%31.99 | 49.88%18.27 | 26.18%68.72 | 48.93%12.57 | 27.93%19.51 |
稀釋每股收益 | 16.15%37.1558 | 26.11%23.04 | 25.55%86.28 | 12.84%14.16 | 12.05%21.86 | 30.84%31.99 | 49.88%18.27 | 26.18%68.72 | 51.88%12.5492 | 27.93%19.51 |
每股派息 | 0 | 0 | 35.00%27 | 35.00%27 | 0 | 0 | 0 | 5.26%20 | 5.26%20 | 0 |
貨幣單位 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 |
會計準則 | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |